[1]
|
Dagamajalu, S., Rex, D., Suchitha, G., et al. (2022) The Network Map of Elabela Signaling Pathway in Physiological and Pathological Conditions. Journal of Cell Communication and Signaling, 16, 145-154.
https://doi.org/10.1007/s12079-021-00640-4
|
[2]
|
Guo, Y., Li, T., Liu, H., et al. (2020) Circulating Levels of Ela-bela and Apelin in the Second and Third Trimesters of Pregnancies with Gestational Diabetes Mellitus. Gynecological Endocrinology, 36, 890-894.
https://doi.org/10.1080/09513590.2020.1739264
|
[3]
|
宋佳玮, 陈临溪, 钟久昌. Elabela-Apelin-APJ系统在血管重构稳态与血管疾病中的调控作用及相关药物研发进展[J]. 药学进展, 2020, 44(12): 894-905.
|
[4]
|
Chng, S., Ho, L., Tian, J., et al. (2013) ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor. De-velopmental Cell, 27, 672-680. https://doi.org/10.1016/j.devcel.2013.11.002
|
[5]
|
Devic, E., Paquereau, L., Vernier, P., et al. (1996) Expression of a New G Protein-Coupled Receptor X-msr Is Associated with an Endothelial Lineage in Xenopus laevis. Mechanisms of Development, 59, 129-140.
https://doi.org/10.1016/0925-4773(96)00585-0
|
[6]
|
Zeng, X., Wilm, T., Sepich, D., et al. (2007) Apelin and Its Receptor Control Heart Field Formation during Zebrafish Gastrulation. Developmental Cell, 12, 391-402. https://doi.org/10.1016/j.devcel.2007.01.011
|
[7]
|
Ma, Z., Song, J., Martin, S., et al. (2021) The Elabela-APJ Axis: A Promising Therapeutic Target for Heart Failure. Heart Failure Reviews, 26, 1249-1258. https://doi.org/10.1007/s10741-020-09957-5
|
[8]
|
Zhong, J., Zhang, Z., Wang, W., et al. (2017) Targeting the Ape-lin Pathway as a Novel Therapeutic Approach for Cardiovascular Diseases. Biochimica et Biophysica acta Molecular Ba-sis of Disease, 1863, 1942-1950.
https://doi.org/10.1016/j.bbadis.2016.11.007
|
[9]
|
Eberlé, D., Marousez, L., Hanssens, S., et al. (2019) Elabela and Apelin Actions in Healthy and Pathological Pregnancies. Cytokine & Growth Factor Reviews, 46, 45-53. https://doi.org/10.1016/j.cytogfr.2019.03.003
|
[10]
|
Erlebacher, A., Fisher, S. (2017) Baby’s First Organ. Scientific American, 317, 46-53.
https://doi.org/10.1038/scientificamerican1017-46
|
[11]
|
Tsai, K., Tullis, B., Jensen, T., et al. (2021) Differential Ex-pression of mTOR Related Molecules in the Placenta from Gestational Diabetes Mellitus (GDM), Intrauterine Growth Restriction (IUGR) and Preeclampsia Patients. Reproductive Biology, 21, Article ID: 100503. https://doi.org/10.1016/j.repbio.2021.100503
|
[12]
|
Tomimatsu, T., Mimura, K., Endo, M., et al. (2017) Pathophysi-ology of Preeclampsia: An Angiogenic Imbalance and Long-Lasting Systemic Vascular Dysfunction. Hypertension re-search, 40, 305-310.
https://doi.org/10.1038/hr.2016.152
|
[13]
|
Paauw, N., Luijken, K., Franx, A., et al. (2016) Long-Term Renal and Cardiovascular Risk after Preeclampsia: Towards Screening and Prevention. Clinical science, 130, 239-246. https://doi.org/10.1042/CS20150567
|
[14]
|
Brosens, I., Puttemans, P., Benagiano, G. (2019) Placental Bed Research: I. The Placental Bed: From Spiral Arteries Remodeling to the Great Obstetrical Syndromes. American Journal of Obstet-rics and Gynecology, 221, 437-456.
https://doi.org/10.1016/j.ajog.2019.05.044
|
[15]
|
Burton, G., Redman, C., Roberts, J., et al. (2019) Pre-Eclampsia: Pathophysiology and Clinical Implications. BMJ, 366, Article No. l2381. https://doi.org/10.1136/bmj.l2381
|
[16]
|
Valensise, H., Vasapollo, B., Gagliardi, G., et al. (2008) Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease. Hypertension, 52, 873-880.
https://doi.org/10.1161/HYPERTENSIONAHA.108.117358
|
[17]
|
Georgiadou, D., Boussata, S., Ranzijn, W., et al. (2019) Peptide Hormone ELABELA Enhances Extravillous trophoblast Differentiation, but Placenta Is Not the Major Source of Circulating ELABELA in Pregnancy. Scientific Reports, 9, Article No. 19077. https://doi.org/10.1038/s41598-019-55650-5
|
[18]
|
Zhou, L., Sun, H., Cheng, R., et al. (2019) ELABELA, as a Po-tential Diagnostic Biomarker of Preeclampsia, Regulates Abnormally Shallow Placentation via APJ. American Journal of Physiology: Endocrinology and Metabolism, 316, E773-E781. https://doi.org/10.1152/ajpendo.00383.2018
|
[19]
|
Ozgen, G., Aydin, G. and Ayvaci, H. (2021) Predictive Role of First-Trimester ELABELA Levels for Late-Onset Preeclampsia. Journal of the College of Physicians and Surgeons Paki-stan, 31, 916-920.
https://doi.org/10.29271/jcpsp.2021.08.916
|
[20]
|
Wang, L., Zhang, Y., Qu, H., et al. (2019) Reduced ELABELA Expression Attenuates Trophoblast Invasion through the PI3K/AKT/mTOR Pathway in Early Onset Preeclampsia. Pla-centa, 87, 38-45.
https://doi.org/10.1016/j.placenta.2019.08.077
|
[21]
|
Yang, P., Read, C., Kuc, R., et al. (2017) Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension. Circulation, 135, 1160-1173.
https://doi.org/10.1161/CIRCULATIONAHA.116.023218
|
[22]
|
Huang, R., Zhu, J., Zhang, L., et al. (2019) Is ELABELA a Reliable Biomarker for Hypertensive Disorders Of Pregnancy? Pregnancy Hypertension, 17, 226-232. https://doi.org/10.1016/j.preghy.2019.06.007
|
[23]
|
Deniz, R., Baykus, Y., Ustebay, S., et al. (2019) Evaluation of Elabela, Apelin and Nitric Oxide Findings in Maternal Blood of Normal Pregnant Women, Pregnant Women with Pre-Eclampsia, Severe Pre-Eclampsia and Umbilical Arteries and Venules of Newborns. Journal of Obstetrics and Gy-naecology, 39, 907-912.
https://doi.org/10.1080/01443615.2019.1572727
|
[24]
|
Ho, L., Van Dijk, M., Chye, S., et al. (2017) ELABELA Deficiency Promotes Preeclampsia and Cardiovascular Malformations in Mice. Science, 357, 707-713. https://doi.org/10.1126/science.aam6607
|
[25]
|
张琼芳. Elabela在子痫前期发病中的作用及其潜在血压调控机制[D]: [硕士学位论文]. 天津: 天津医科大学, 2020.
|
[26]
|
Johns, E., Denison, F., Norman, J., et al. (2018) Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends in Endocrinology and Metabolism, 29, 743-754. https://doi.org/10.1016/j.tem.2018.09.004
|
[27]
|
Guariguata, L., Linnenkamp, U., Beagley, J., et al. (2014) Global Estimates of the Prevalence of Hyperglycaemia in Pregnancy. Diabetes Research and Clinical Practice, 103, 176-185. https://doi.org/10.1016/j.diabres.2013.11.003
|
[28]
|
Fritsche, L., Hummel, J., Wagner, R., et al. (2022) The German Gestational Diabetes Study (PREG), a Prospective Multicentre Cohort Study: Rationale, Methodology and Design. BMJ Open, 12, Article ID: e058268.
https://doi.org/10.1136/bmjopen-2021-058268
|
[29]
|
Wang, W., Cao, Y., Cai, N., et al. (2022) Influence of One-Day Diabetes Mellitus Clinic Management on Blood Glucose Control and Prognosis in Patients with Gestational Diabetes Mellitus. Gynecological endocrinology, 35, 324-328.
https://doi.org/10.1080/09513590.2022.2040474
|
[30]
|
Peltokorpi, A., Irina, L., Liisa, V., et al. (2022) Preconceptu-al Leptin Levels in Gestational Diabetes and Hypertensive Pregnancy. Hypertension in Pregnancy, 41, 70-77. https://doi.org/10.1080/10641955.2022.2033763
|
[31]
|
Bellos, I., Fitrou, G., Pergialiotis, V., et al. (2019) Serum Levels of Adipokines in Gestational Diabetes: A Systematic Review. Journal of Endocrinological Investigation, 42, 621-631. https://doi.org/10.1007/s40618-018-0973-2
|
[32]
|
Bao, W., Baecker, A., Song, Y., et al. (2015) Adipokine Levels during the First or Early Second Trimester of Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus: A Systematic Review. Metabolism, 64, 756-764.
https://doi.org/10.1016/j.metabol.2015.01.013
|
[33]
|
Elsehmawy, A., El-Toukhy, S., Seliem, N., et al. (2019) Apelin and Chemerin as Promising Adipokines in Children with Type 1 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity, 12, 383-389.
https://doi.org/10.2147/DMSO.S189264
|
[34]
|
Behram, M., Oğlak, S. and Dağ, İ. (2021) Circulating Levels of Ela-bela in Pregnant Women Complicated with Intrauterine Growth Restriction. Journal of Gynecology Obstetrics and Hu-man Reproduction, 50, Article ID: 102127.
https://doi.org/10.1016/j.jogoh.2021.102127
|
[35]
|
Dawid, M., Mlyczyńska, E., Jurek, M., et al. (2021) Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development—An Overview. Cells, 11, Article No. 99. https://doi.org/10.3390/cells11010099
|
[36]
|
Telejko, B., Kuzmicki, M., Wawrusiewicz-Kurylonek, N., et al. (2010) Plasma Apelin Levels and Apelin/APJ mRNA Expression in Patients with Gestational Diabetes Mellitus. Diabe-tes Research and Clinical Practice, 87, 176-183.
https://doi.org/10.1016/j.diabres.2009.10.018
|
[37]
|
Zhang, Y., Wang, Y., Luo, M., et al. (2019) Elabela Protects against Podocyte Injury in Mice with Streptozocin-induced Diabetes by Associating with the PI3K/Akt/mTOR Pathway. Peptides, 114, 29-37.
https://doi.org/10.1016/j.peptides.2019.04.005
|
[38]
|
Sáez, T., Salsoso, R., Leiva, A., et al. (2018) Human Umbilical Vein Endothelium-Derived Exosomes Play a Role in Foetoplacental Endothelial Dysfunction in Gestational Diabetes Mellitus. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1864, 499-508. https://doi.org/10.1016/j.bbadis.2017.11.010
|